BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34346865)

  • 1. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 2. Could new COVID variants undermine vaccines? Labs scramble to find out.
    Callaway E
    Nature; 2021 Jan; 589(7841):177-178. PubMed ID: 33432212
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron likely to weaken COVID vaccine protection.
    Callaway E
    Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
    [No Abstract]   [Full Text] [Related]  

  • 7. How 'killer' T cells could boost COVID immunity in face of new variants.
    Ledford H
    Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
    [No Abstract]   [Full Text] [Related]  

  • 8. Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice.
    Wang W; Huang B; Zhu Y; Tan W; Zhu M
    Cell Mol Immunol; 2021 Mar; 18(3):749-751. PubMed ID: 33580169
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.
    Ahluwalia P; Vaibhav K; Ahluwalia M; Mondal AK; Sahajpal N; Rojiani AM; Kolhe R
    Front Immunol; 2021; 12():660019. PubMed ID: 34046033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 12. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
    Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
    EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Proteins under 70 Kilodaltons in Size Prevent the Development of Long-Lasting B-Cell Immune Memory and IgG2a Prevention in COVID-19 Vaccines.
    Martín Oncina J
    Crit Rev Immunol; 2020; 40(6):465-473. PubMed ID: 33900691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus variants are spreading in India - what scientists know so far.
    Vaidyanathan G
    Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409
    [No Abstract]   [Full Text] [Related]  

  • 15. Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA.
    Piano Mortari E; Russo C; Vinci MR; Terreri S; Fernandez Salinas A; Piccioni L; Alteri C; Colagrossi L; Coltella L; Ranno S; Linardos G; Agosta M; Albano C; Agrati C; Castilletti C; Meschi S; Romania P; Roscilli G; Pavoni E; Camisa V; Santoro A; Brugaletta R; Magnavita N; Ruggiero A; Cotugno N; Amodio D; Ciofi Degli Atti ML; Giorgio D; Russo N; Salvatori G; Corsetti T; Locatelli F; Perno CF; Zaffina S; Carsetti R
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies.
    Xie X; Han JB; Ma G; Feng XL; Li X; Zou QC; Deng ZH; Zeng J
    Zool Res; 2021 Nov; 42(6):789-791. PubMed ID: 34704423
    [No Abstract]   [Full Text] [Related]  

  • 17. 'Killer' immune cells still recognize Omicron variant.
    Ledford H
    Nature; 2022 Jan; 601(7893):307. PubMed ID: 35017690
    [No Abstract]   [Full Text] [Related]  

  • 18. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.
    Ludwig H; San-Miguel J; Munshi N; Sonneveld P; Mateos MV; Moreau P; Terpos E
    Am J Hematol; 2021 Aug; 96(8):896-900. PubMed ID: 34057243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.